|
|
| Phenytoin | ||
| Order Code: DPH
Order Form: A-1a Therapeutic Drug Analysis or IPR Req |
Chemistry 6240 RCP 356-3527 |
|
Specimen |
Plasma | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Call laboratory for additional acceptable specimen collection containers. | ||
Minimum: |
2 ml; light green top tube or one 0.6 ml microtubes. (Sufficient for one or more anticonvulsant drugs). | ||
Testing Schedule: |
24 hrs/day, 7 days a week, including holidays. | ||
Analytic Time: |
2 hours (upon receipt in laboratory) | ||
Reference Range: |
10-20 mcg/ml Critical value: >40 mcg/ml | ||
Comments: |
Fosphenytoin is a pro-drug that is metabolized to phenytoin. The inactive pro-drug is cross-reactive with serum phenytoin when measured by immunoanalytic assays. To avoid significant false elevations in serum phenytoin or serum free phenytoin, phenytoin serum specimens should not be drawn for 2 hours following completion of an I.V. fosphenytoin infusion, or 4 hours following an I.M. fosphenytoin dose. | ||
Test Limitations: |
Criterion: recovery plus or minus 0.6 ug/ml of initial value at concentrations less than 6 ug/ml or plus or minus 10% of initial value at concentrations greater than 6 ug/ml. Icterus: No significant interference from bilirubin up to an I index of 60 (approximate bilirubin concentration: 60 mg/dl). Hemolysis: No significant interference from hemoglobin up to an H index of 1000 (approximate hemoglobin concentration: 1000 mg/dl). Lipemia (Intralipid): No significant interference from lipemia up to an L index of 1000. (approximate triglycerides concentration: 2000 mg/dl). There is poor correlation between turbidity and triglycerides concentration. No significant interference from total protein up to 12 g/dl. No significant interference from rheumatoid factors up to 100 IU/ml. The incidence of patients with antibodies to E. coli beta-galactosidase is extremely low. However, some samples containing such antibodies can result in artificially high phenytoin results that do not fit the clinical profile. If this occurs, contact Customer Technical Support. As with any assay employing mouse antibodies, the possibility exists for interference by human anti-mouse antibodies (HAMA) in the sample, which could cause falsely elevated results. | ||
Methodology: |
EIA (Enzymatic ImmunoAssay) | ||
CPT Code: |
80185 | ||
See also: Phenytoin, Free, Plasma | |||
See Additional Information: Chemistry Critical Lab Values |
Updated: 08/30/2006
Note: The information contained in this handbook is for use by personnel of University of Iowa Health Care. No other use is implied or intended.